Impact of tocilizumab monotherapy on patient-reported outcomes in patients with rheumatoid arthritis from two randomised controlled trials

OBJECTIVE: Two randomised controlled trials, AMBITION (NCT00109408) and ADACTA (NCT01119859), showed tocilizumab (TCZ) monotherapy superior to methotrexate (MTX) and adalimumab (ADA) monotherapy, respectively, for improving rheumatoid arthritis (RA) disease activity. This study compared the benefit...

Descripción completa

Detalles Bibliográficos
Autores principales: Strand, Vibeke, Michalska, Margaret, Birchwood, Christine, Pei, Jinglan, Tuckwell, Katie, Finch, Rebecca, Gabay, Cem, Kavanaugh, Arthur, Jones, Graeme
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2017
Materias:
Rheumatoid Arthritis
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5604726/
https://www.ncbi.nlm.nih.gov/pubmed/28955499
http://dx.doi.org/10.1136/rmdopen-2017-000496

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5604726/
https://www.ncbi.nlm.nih.gov/pubmed/28955499
http://dx.doi.org/10.1136/rmdopen-2017-000496

Ejemplares similares